GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Today
—
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Sanofi India Ltd
Sanofi India Board Meeting to Consider Q2/9M FY26 Results and Interim Dividend
RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 19 Oct 2026, 08:03 PM IST  ·  BSE ID: 96c9fbfa-7692-44cc-a09a-d5b714b509df
View Original BSE Filing (PDF)
💡
In Simple Terms
Sanofi India's board will meet on October 29, 2026, to review financial results and may announce a dividend.
🤖 AI Summary
  • Sanofi India's Board will convene on Thursday, October 29, 2026, to review financial results.
  • The board meeting agenda includes considering and approving Unaudited Financial Results for Q2 and 9M FY26.
  • Consideration, declaration, and approval of an Interim dividend for financial year 2026 is also on the agenda.
  • Trading window for company shares remains closed from October 1, 2026, until 48 hours post-results.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders. Shareholders should await the outcome of the board meeting on October 29, 2026.
👤
Who Is Affected
All shareholders of Sanofi India Limited will be affected by any potential interim dividend declaration and by the upcoming financial performance announcement.
🔍
Management Signal
The decision to consider an interim dividend signals management's ongoing commitment to shareholder returns, subject to financial performance.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Sanofi India's Q2 and 9M FY26 unaudited financial results announcement on October 29, 2026.
Interim dividend declaration details for FY2026, if approved.
Trading window reopening post-results, expected around November 1, 2026.
LOW RISK This filing is a routine board meeting intimation, carrying minimal inherent risk.
💡 Investor Takeaway
Sanofi India Limited has scheduled a Board Meeting for October 29, 2026, to approve unaudited financial results for the quarter and nine-months ended September 30, 2026. The board will also consider declaring an Interim dividend for FY2026.
📅 Company Track Record
Sanofi India's past filings include an investor call for Q1/H1 FY27 results on August 5, 2026. The company reported Q4 FY26 unaudited financial results with its insulin portfolio growing 19% YoY to ₹4,723 Million revenue, despite an 11.6% total revenue decline due to partnership transitions.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
When is Sanofi India Limited's next Board Meeting scheduled?
Sanofi India Limited's Board of Directors meeting is scheduled for Thursday, October 29, 2026.
What is the agenda for Sanofi India Limited's upcoming Board Meeting?
The board meeting will consider and approve the Unaudited Financial Results for the quarter and nine-months ended September 30, 2026, and consider, declare, and approve an Interim dividend, if any, for the financial year 2026.
When did the trading window close for Sanofi India Limited shares?
The trading window for Sanofi India Limited shares closed from October 1, 2026, and will remain closed until 48 hours after the announcement of the results to the Stock Exchanges.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.